Charles Schwab Investment Management Inc Stereotaxis, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 22,696 shares of STXS stock, worth $41,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,696
Previous 22,696
-0.0%
Holding current value
$41,306
Previous $39,000
51.28%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding STXS
# of Institutions
88Shares Held
41.6MCall Options Held
86.5KPut Options Held
43.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$24.9 Million8.6% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$6.97 Million6.2% of portfolio
-
Redmile Group, LLC San Francisco, CA3.31MShares$6.02 Million0.34% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.76MShares$5.02 Million11.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$4.76 Million0.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $136M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...